MICROBOOSTING OF ATAZANAVIR 300 MG WITH 50 MG VERSUS 100MG OF RITONAVIR DAILY IN HIV-INFECTED PATIENTS

Conference Reports for NATAP

16th International Workshop
on Clinical Pharmacology of HIV
and Hepatitis Therapy
May 26-28, 2015
Washington, DC


MICROBOOSTING OF ATAZANAVIR 300 MG WITH 50 MG VERSUS 100MG OF RITONAVIR DAILY IN HIV-INFECTED PATIENTS

	Reported by Jules Levin 16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, May 26-28, 2015, Washington, DC P Giguere, C laPorte, J Angel, G Zhang, I Seguin, E Sabri, B Cameron.